Addition of lomustine for bevacizumab-refractory recurrent glioblastoma.
Tonder M, Eisele G, Weiss T, Hofer S, Seystahl K, Valavanis A, Stupp R, Weller M, Roth P.
Tonder M, et al. Among authors: hofer s.
Acta Oncol. 2014 Oct;53(10):1436-40. doi: 10.3109/0284186X.2014.920960. Epub 2014 May 26.
Acta Oncol. 2014.
PMID: 24862539
Free article.
No abstract available.